Introduction
============

Cardiovascular disease is one of the leading causes of premature death in Japan and worldwide^[@bib1]--[@bib3])^. Although recent decades have seen reductions in the age-adjusted incidence rates of coronary heart disease and stroke in Japan, the actual number of events are expected to increase because of an aging population^[@bib4],\ [@bib5])^. Strategies based on better knowledge of cardiovascular risk factors are needed to effectively prevent cardiovascular events in Japan.

Several observational studies have investigated the link between sleep duration and incidence of or mortality due to cardiovascular disease. Some have suggested a U-shaped association, i.e., increased risk in individuals with short sleep duration as well as those with long sleep duration^[@bib6]--[@bib12])^. Possible mechanisms underlying the U-shaped association include elevated blood pressure^[@bib13])^, impaired glucose tolerance^[@bib14])^, and increased inflammation^[@bib15])^ in those with insufficient sleep and raised inflammatory markers in those with long sleep duration^[@bib16])^. Observational studies have also reported an association between sleep duration and subclinical atherosclerosis of coronary or carotid arteries^[@bib17]--[@bib24])^, which has been shown to be an important intermediate marker of cardiovascular disease^[@bib25],\ [@bib26])^. Some studies reported comparable associations between men and women (SUMSUNG) while others reported the relationship in male participants only (CARDIA IMT). However, current evidence is derived mostly from studies of Western populations; the extent to which these data are applicable to Asian populations, including the Japanese, is uncertain.

Aim
===

The aim of this study was to investigate associations of self-reported sleep duration with coronary arteries calcification (CAC) and carotid intima media thickness (IMT) among Japanese men.

Methods
=======

Study Design and Participants
-----------------------------

SESSA (Shiga Epidemiological Study of Subclinical Atherosclerosis) is an epidemiological study of men randomly selected from the general population of a Japanese city, details of which have previously been described^[@bib27])^. In brief, from May 2006 to March 2008, 1094 community-dwelling men aged 40--79 years were selected based on an age-stratified random sample from the Basic Residents\' Register of Kusatsu City and received comprehensive physical examinations. After exclusion of a participant without information on sleep duration, a total of 1093 men were included in the present cross-sectional analysis of CAC. After further exclusion of 33 men without information on carotid ultrasound, a total of 1060 men were included in the analysis of carotid IMT. The study was approved by the Institutional Review Board of Shiga University of Medical Science (No. 17--19, 17--83); all participants provided written informed consent.

Sleep Duration
--------------

At the baseline examination, information on average sleep duration on weekdays in the 30 days prior to enrolment was obtained using a questionnaire and confirmed by trained staff. Five participant groups defined by the self-reported sleep duration (\< 5.5, 5.5--6.4, 6.5--7.4, 7.5--8.4, and ≥ 8.5 h per day) were used in the present analysis.

Other Risk Factors
------------------

A self-administered questionnaire was used to obtain information on demography, smoking habits (never, past, and current), alcohol drinking (types of alcohol, frequency, quantity), physical activity, and use of medication(s) for hypertension, dyslipidemia, diabetes mellitus, and sleep disorder. Regular exercise was defined as sports or other forms of exertion at least once a week. Participants with depressive symptoms were defined as those who had the Center for Epidemiologic Studies Depression Scale (CES-D) score ≥ 16^[@bib28])^. Weight and height were measured to calculate body mass index (BMI). Blood pressure was measured using an automated sphygmomanometer (BP-8800; Omron Colin, Tokyo, Japan) with the patient in a seated position after a 5-min rest; the mean of two measurements was used as the final value. Venous blood was drawn after a 12-h fast and centrifuged soon after coagulation; plasma glucose levels were measured from sodium fluoride-treated plasma using a hexokinase glucose-6-phosphate-dehydrogenase enzymatic assay; and hemoglobin A1c (HbA1c) levels were measured using a latex agglutination inhibition assay as per Japan Diabetes Society (JDS) methods and converted into National Glycohemoglobin Standardization Program (NGSP) values using the following formula: HbA1c (NGSP) (%) = 1.02 × HbA1c (JDS) (%) + 0.25^[@bib29])^. The concentration of standard lipids, including total cholesterol, was measured using enzymatic methods; high-density lipoprotein (HDL) cholesterol was measured after heparin-calcium precipitation. Lipid measurements were standardized per Center for Disease Control and Prevention/Cholesterol Reference Method Laboratory Network (CDC/CRMLN) guidelines^[@bib30])^. Participants with regular exercise were defined as those who regularly exercised ≥ 1 h/week.

Coronary Artery Calcification
-----------------------------

Detailed procedures for CAC measurement have previously been described^[@bib31])^. CAC was assessed by either electron-beam computed tomography (EBCT) (*n* = 762, 69.7%) using a C-150 scanner (Imatron, South San Francisco, CA, USA), or 16-channel multidetector-row CT (MDCT) (*n* = 331) using an Aquilion scanner (Toshiba, Tokyo, Japan). Images were obtained from the level of the aortic root through the heart in 3-mm slices with a scan time of 100 ms (EBCT) or 320 ms (MDCT). Images were acquired at 70% of the cardiac cycle using electrocardiogram triggering during a single breath-hold. Quantification of CAC was performed using a DICOM workstation and AccuImage software (AccuImage Diagnostics, South San Francisco, CA, USA). CAC was considered present if there were a minimum of three contiguous pixels (each with area 1 mm^2^) with a density of ≥ 130 Hounsfield units (HU). A region of interest was placed around each high-density lesion in the epicardial coronary arteries. The peak density and area of the individual coronary calcifications were measured and the CAC score calculated per the Agatston method^[@bib32])^. All CT images were read by one physician, trained in CT reading at the Cardiovascular Institute of the University of Pittsburgh, who was blinded to participants\' demographics. The protocol described above was adopted from a separate cohort study performed by our research group^[@bib33])^, which showed high inter-rater reliability (intraclass correlation coefficient 0.98)^[@bib34])^. In the present analysis, the presence of CAC was defined as a CAC score ≥ 10^[@bib35])^, but sensitivity analyses were conducted using a definition of a CAC score \> 0.

Intimal Media Thickness of the Carotid Artery
---------------------------------------------

The IMT measurement protocol has previously been described^[@bib36])^. Using a 7.5 MHz probe (Xario-660A; Toshiba Medical Systems, Tokyo, Japan), detailed B-mode images of the right and left common carotid artery (CCA), common carotid bifurcation, and internal carotid artery (ICA) were obtained with a standardized method established by the Ultrasound Research Laboratory of the University of Pittsburgh^[@bib37])^. Images from the following segments were digitized: near and far walls of the distal CCA (1 cm proximal to the carotid bulb); far wall of the bulb; and a 1-cm area of the far wall of the ICA (a total of four locations per side). The carotid IMT was traced with an automatic image-reading program (AMS; Chalmers University of Technology, Gothenburg, Sweden). In this study, the mean carotid IMT comprised the mean of all average readings across the eight locations from the CCA, bulb, and ICA^[@bib36])^.

Statistical Analysis
--------------------

Each participant characteristic was described as a mean (standard deviation \[SD\]) or median (interquartile range \[IQR\]) for continuous variables and a percentage for categorical variables. Differences were evaluated using the Kruskal-Wallis or chi-squared test, as appropriate. Crude and multivariable-adjusted logistic regression models were used to estimate odds ratios (OR) and 95% confidence intervals (CI) for the presence of CAC. Participants with a sleep duration of 6.5--7.4 h were used as reference, in accordance with findings from previous studies^[@bib6]--[@bib12])^. Analysis of covariance (ANCOVA) was used to test for associations between sleep duration and mean carotid IMT. The multivariable-adjusted models included confounding factors of age, BMI, smoking status, regular exercise, alcohol consumption, and type of CT (model 1). We also conducted multivariable analysis with further adjustment for possible mediators (i.e., established cardiovascular risk factors that have been shown to be associated with sleep duration) including systolic blood pressure, total cholesterol, HDL cholesterol, HbA1c, and medication status^[@bib38],\ [@bib39])^ (model 2). Difference in associations between subgroups (age group, BMI group, smoking status, alcohol consumption, working status, use of sleeping pills, or presence of depressive symptoms) were assessed by adding interaction terms to the model. Analyses were performed using SAS version 9.4 (SAS Institute, Cary, NC, USA). Two-tailed *p* values \< 0.05 were considered significant.

Results
=======

Participant characteristics are shown in **[Table 1](#T1){ref-type="table"}**. Participants with longer sleep durations were older, had lower BMIs, and higher systolic blood pressures than those with shorter sleep durations.

###### Characteristics of male participants enrolled in SESSA (2006--2008) stratified by sleep duration (*n* = 1093)

                                                                           Sleep duration (hours)                                                                        
  -------------------------------------------------------- --------------- ------------------------ --------------- --------------- --------------- -------------------- -----------
  Age (years)                                              64.1 (9.9)      62.3 (11.6)              61.5 (10.8)     63.7 (9.4)      66.7 (7.9)      69.9 (7.5)           \< 0.0001
  Body mass index (kg/m^2^)                                23.6 (3.0)      23.7 (2.9)               24.0 (2.9)      23.7 (2.9)      23.4 (3.0)      22.3 (3.3)           0.002
  Systolic blood pressure (mmHg)                           136.5 (19.1)    137.0 (21.9)             135.5 (19.3)    135.8 (18.2)    136.6 (18.8)    142.2 (18.1)         0.054
  Diastolic blood pressure (mmHg)                          79.7 (10.9)     81.1 (12.6)              79.7 (11.3)     79.8 (10.5)     79.0 (10.5)     78.7 (10.3)          0.518
  Total cholesterol (mg/dL)                                208.1 (33.7)    207.8 (32.0)             209.2 (34.7)    207.3 (31.6)    210.1 (35.5)    203.7 (37.6)         0.781
  LDL cholesterol (mg/dL)[\*](#tf1){ref-type="table-fn"}   124.7 (31.6)    123.7 (31.9)             125.0 (31.5)    124.4 (29.4)    127.2 (33.9)    120.1 (34.9)         0.638
  HDL cholesterol (mg/dL)                                  58.6 (16.9)     58.6 (17.0)              59.5 (17.2)     58.2 (16.4)     57.9 (17.0)     59.8 (18.0)          0.767
  Triglyceride (mg/dL)                                     106 (77--150)   111.5 (78--157)          106 (77--149)   106 (77--153)   108 (75--147)   96.5 (76.5--142.5)   0.853
  Blood glucose (mg/dL)                                    102.7 (21.2)    101.7 (21.6)             102.2 (19.3)    102.8 (21.4)    104.8 (24.0)    100.3 (17.0)         0.657
  HbA1c (%)                                                5.7 (0.8)       5.6 (0.7)                5.6 (0.8)       5.7 (0.8)       5.8 (0.9)       5.6 (0.8)            0.040
  Current smokers                                          (32.0)          (33.9)                   (30.9)          (30.5)          (33.6)          (36.3)               0.331
  Regular exercise                                         (43.5)          (34.8)                   (41.0)          (42.4)          (53.8)          (41.3)               0.006
  Alcohol consumption (g/day)                              23.1 (27.3)     26.5 (33.3)              23.5 (27.3)     21.6 (25.5)     23.1 (25.9)     24.5 (29.3)          0.943
  Medication for hypertension                              (28.8)          (30.5)                   (27.0)          (27.7)          (28.7)          (38.8)               0.317
  Medication for dyslipidemia                              (11.3)          (13.7)                   (12.2)          (10.9)          (9.5)           (12.7)               0.773
  Medication for diabetes                                  (10.3)          (11.0)                   (7.9)           (11.2)          (12.6)          (6.3)                0.312
  Medication for sleep                                     (5.5)           (7.6)                    (7.6)           (5.3)           (3.1)           (2.5)                0.131
  Depressive symptoms^[†](#tf2){ref-type="table-fn"}^      (7.9)           (11.0)                   (13.3)          (4.8)           (7.6)           (0.0)                \< 0.0001

Values are expressed as mean (standard deviation), median (interquartile range) or (%).

Calculated by the formula of Friedwald *et al.*

Center for Epidemiologic Studies Depression Scale score ≥ 16

*P* values were estimated using Kruskal-Willis test for continuous and *χ*^2^ test for categorical variables.

IQR: interquartile range; LDL: low-density lipoprotein; HbA1c: hemoglobin A1c; HDL: high-density lipoprotein; SD: standard deviation; SESSA: Shiga Epidemiological Study of Subclinical Atherosclerosis

The number of participants with CAC was 538 (49.2%). The prevalence was 50.0%, 43.9%, 50.0%, 49.3%, and 62.5% for individuals with sleep durations of \< 5.5, 5.5--6.4, 6.5--7.4, 7.5--8.4, and ≥ 8.5 h, respectively (**[Table 2](#T2){ref-type="table"}**). In a crude analysis, individuals with sleep duration ≥ 8.5 h had significantly higher CAC prevalence (OR 1.67; 95% CI, 1.02--2.73; *p* = 0.043) than those with 6.5--7.4 h. However, the difference was not statistically significant after adjustment for age (OR 1.01; 95% CI, 0.60--1.72; *p* = 0.961) or for age and other cardiovascular risk factors (OR 1.08; 95% CI, 0.63--1.86; *p* = 0.776). Findings were similar when subjects with stroke and/or myocardial infarction were excluded from the analysis (**[Supplementary Table 1](#T4){ref-type="table"}**) or when a CAC score of \> 0 was used as threshold (**[Supplementary Table 2](#T5){ref-type="table"}**). There were no clear differences in association between sleep duration and CAC when participants were further stratified by age group, BMI group, smoking status, alcohol consumption, employment status, use of sleeping pills, or presence of depressive symptoms (all *p* \> 0.2 for heterogeneity; **[Supplementary Table 3](#T6){ref-type="table"}**). There were also comparable associations between sleep duration and CAC between the 762 participants who were assessed using EBCT and the 331 assessed using MDCT (*p* = 0.289 for heterogeneity).

###### Prevalence and odds ratio of coronary artery calcification[\*](#tf4){ref-type="table-fn"} among male participants enrolled in SESSA (2006--2008) stratified by sleep duration (*n* = 1093)

                                                                                Sleep duration (hours)                                                        
  ----------------------------------------------------------------------------- ------------------------ ------------------- ------------ ------------------- -------------------
  CAC, n (%)                                                                    59 (50.0)                122 (43.9)          197 (50.0)   110 (49.3)          50 (62.5)
  Crude OR (95%CI)                                                              1.00 (0.66--1.51)        0.78 (0.58--1.07)   1.00         0.97 (0.70--1.35)   1.67 (1.02--2.73)
  Age-adjusted OR (95%CI)                                                       1.12 (0.71--1.77)        0.90 (0.64--1.26)   1.00         0.75 (0.53--1.06)   1.01 (0.60--1.72)
  Multivariable-adjusted OR (95%CI) (model 1)^[†](#tf5){ref-type="table-fn"}^   1.12 (0.71--1.79)        0.87 (0.62--1.23)   1.00         0.72 (0.51--1.03)   1.08 (0.63--1.86)
  Multivariable-adjusted OR (95%CI) (model 2)^[‡](#tf6){ref-type="table-fn"}^   1.07 (0.67--1.71)        0.85 (0.60--1.21)   1.00         0.71 (0.49--1.03)   1.03 (0.59--1.79)

Defined as coronary artery calcification score ≥ 10.

Adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, and types of computed tomography scan

Adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, types of computed tomography scan, systolic blood pressure, total cholesterol, high density lipoprotein cholesterol, hemoglobin A1c, and medication status.

CAC: coronary artery calcification; CI: confidence interval; OR: odds ratio; SESSA: Shiga Epidemiological Study of Subclinical Atherosclerosis

###### Prevalence and odds ratios of coronary artery calcification[\*](#tf9){ref-type="table-fn"} among male participants without prior stroke or myocardial infarction in SESSA (2006--2008) stratified by sleep duration (*n* = 1027)

                                                                                 Sleep duration (hours)                                                        
  ------------------------------------------------------------------------------ ------------------------ ------------------- ------------ ------------------- -------------------
  CAC, n (%)                                                                     50 (47.2)                109 (41.6)          184 (49.1)   99 (46.9)           43 (58.9)
  Crude OR (95%CI)                                                               0.93 (0.60--1.43)        0.74 (0.54--1.02)   1.00         0.92 (0.66--1.29)   1.49 (0.90--2.47)
  Age-adjusted OR (95%CI)                                                        1.08 (0.67--1.74)        0.84 (0.59--1.18)   1.00         0.71 (0.50--1.02)   0.94 (0.55--1.61)
  Multivariable-adjusted OR (95%CI) (model 1)^[†](#tf10){ref-type="table-fn"}^   1.09 (0.67--1.77)        0.81 (0.57--1.15)   1.00         0.68 (0.47--0.99)   1.00 (0.58--1.75)
  Multivariable-adjusted OR (95%CI) (model 2)^[‡](#tf11){ref-type="table-fn"}^   1.03 (0.63--1.70)        0.83 (0.58--1.18)   1.00         0.66 (0.45--0.96)   0.94 (0.53--1.67)

Defined as coronary artery calcification score ≥ 10.

Adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, and types of computed tomography scan

Adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, types of computed tomography scan, systolic blood pressure, total cholesterol, high density lipoprotein cholesterol, hemoglobin A1c, and medication status

CAC: coronary artery calcification; CI: confidence interval; OR: odds ratio; SESSA: Shiga Epidemiological Study of Subclinical Atherosclerosis

###### Prevalence and odds ratios of coronary artery calcification (defined as coronary artery calcification score \> 0) among male participants in SESSA (2006--2008) stratified by sleep duration (*n* = 1093)

                                                                                 Sleep duration (hours)                                                        
  ------------------------------------------------------------------------------ ------------------------ ------------------- ------------ ------------------- -------------------
  CAC, n (%)                                                                     82 (69.5)                170 (61.2)          257 (65.2)   150 (67.3)          58 (72.5)
  Crude OR (95%CI)                                                               1.21 (0.78--1.89)        0.84 (0.61--1.15)   1.00         1.10 (0.77--1.55)   1.41 (0.83--2.39)
  Age-adjusted OR (95%CI)                                                        1.52 (0.93--2.50)        1.02 (0.72--1.45)   1.00         0.81 (0.56--1.18)   0.79 (0.45--1.40)
  Multivariable-adjusted OR (95%CI) (model 1)[\*](#tf12){ref-type="table-fn"}    1.72 (1.00--2.95)        1.03 (0.71--1.51)   1.00         0.78 (0.52--1.15)   0.99 (0.54--1.81)
  Multivariable-adjusted OR (95%CI) (model 2)^[†](#tf13){ref-type="table-fn"}^   1.63 (0.94--2.80)        1.03 (0.70--1.52)   1.00         0.75 (0.50--1.11)   0.95 (0.52--1.76)

Adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, and types of computed tomography scan

Adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, types of computed tomography scan, systolic blood pressure, total cholesterol, high density lipoprotein cholesterol, hemoglobin A1c, and medication status

CAC: coronary artery calcification; CI: confidence interval; OR: odds ratio; SESSA: Shiga Epidemiological Study of Subclinical Atherosclerosis

###### Odds ratios of coronary artery calcification[\*](#tf14){ref-type="table-fn"} among selected subgroups of men enrolled in SESSA (2006--2008) stratified by sleep duration (*n* = 1093)

  Subgroup                                                               Sleep duration (hours)   *p* ^[‡](#tf16){ref-type="table-fn"}^                                                  
  ---------------------------------------------------------------------- ------------------------ --------------------------------------- ------ ------------------- ------------------- -------
  Age \< 65 years (*n* = 549)                                            1.10 (0.57--2.10)        0.91 (0.57--1.47)                       1.00   0.67 (0.38--1.17)   1.86 (0.70--4.98)   0.711
  Age ≥ 65 years (*n* = 544)                                             1.23 (0.63--2.41)        0.77 (0.47--1.26)                       1.00   0.79 (0.49--1.26)   1.05 (0.56--1.97)   
                                                                                                                                                                                         
  BMI \< 25 Kg/m^2^ (*n* = 771)                                          1.02 (0.58--1.77)        0.80 (0.52--1.21)                       1.00   0.81 (0.54--1.22)   1.00 (0.55--1.82)   0.596
  BMI ≥ 25 Kg/m^2^ (*n* = 322)                                           1.21 (0.51--2.91)        1.01 (0.54--1.90)                       1.00   0.54 (0.26--1.11)   0.87 (0.27--2.86)   
                                                                                                                                                                                         
  Smoker (*n* = 350)                                                     1.11 (0.49--2.55)        1.05 (0.56--1.96)                       1.00   0.76 (0.40--1.45)   0.57 (0.23--1.43)   0.369
  Non-smoker (*n* = 743)                                                 1.09 (0.62--1.92)        0.78 (0.51--1.18)                       1.00   0.67 (0.43--1.04)   1.60 (0.79--3.25)   
                                                                                                                                                                                         
  Alcohol consumption \< 46 g/day (*n* = 886)                            0.98 (0.58--1.64)        0.88 (0.60--1.30)                       1.00   0.65 (0.44--0.97)   0.85 (0.46--1.57)   0.297
  Alcohol consumption ≥ 46 g/day (*n* = 207)                             2.46 (0.82--7.35)        0.94 (0.42--2.13)                       1.00   1.24 (0.54--2.85)   2.88 (0.85--9.77)   
                                                                                                                                                                                         
  Working (*n* = 722)                                                    1.15 (0.65--2.01)        0.89 (0.58--1.37)                       1.00   0.81 (0.51--1.28)   0.79 (0.37--1.68)   0.450
  Retired (*n* = 371)                                                    1.20 (0.51--2.84)        0.87 (0.48--1.59)                       1.00   0.61 (0.34--1.09)   1.60 (0.69--3.70)   
                                                                                                                                                                                         
  Did not use sleeping pills (*n* = 1033)                                1.11 (0.69--1.78)        0.89 (0.62--1.27)                       1.00   0.72 (0.50--1.04)   1.14 (0.66--1.98)   0.902
  Used sleeping pills (*n* = 60)                                         1.69 (0.14--20.74)       0.62 (0.13--3.07)                       1.00   0.35 (0.03--3.94)   0.06 (0.00--1.70)   
                                                                                                                                                                                         
  No depressive symptoms^[†](#tf15){ref-type="table-fn"}^ (*n* = 1007)   1.30 (0.73--2.31)        0.92 (0.61--1.40)                       1.00   0.77 (0.51--1.19)   1.22 (0.64--2.32)   0.726
  Depressive symptoms (*n* = 86)                                         0.61 (0.06--6.17)        0.51 (0.08--3.11)                       1.00   0.17 (0.02--1.68)   Not calculable      

Model adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, and types of computed tomography scan except for each stratified variable.

Defined as coronary artery calcification score ≥ 10.

Center for Epidemiologic Studies Depression Scale score ≥ 16

Test for heterogeneity

CI: confidence interval; OR: odds ratio; SESSA: Shiga Epidemiological Study of Subclinical Atherosclerosis

The overall mean carotid IMT was 0.86 mm; mean values were 0.85 mm, 0.83 mm, 0.85 mm, 0.88 mm, and 0.90 mm for individuals with sleep durations of \< 5.5, 5.5--6.4, 6.5--7.4, 7.5--8.4, and ≥ 8.5 h, respectively (**[Table 3](#T3){ref-type="table"}**). There were no significant differences among the five groups (all *p* \> 0.1). There were also no important associations between sleep duration and mean carotid IMT after adjustment for age or after adjustment for age and other cardiovascular risk factors (all *p* \> 0.1). There were no clear difference in associations between sleep duration and carotid IMT among subgroups (*p* \> 0.05 for heterogeneity; **[Supplementary Table 4](#T7){ref-type="table"}**).

###### Mean IMT among male participants enrolled in SESSA (2006--2008), stratified by sleep duration (*n* = 1060)

                                                                                      Sleep duration (hours)                                                                   
  ----------------------------------------------------------------------------------- ------------------------ ---------------------- ------------------- -------------------- ---------------------
  Crude mean, mm (95%CI)                                                              0.85 (0.82--0.89)        0.83 (0.81--0.85)      0.85 (0.83--0.87)   0.88 (0.86--0.91)    0.90 (0.85--0.94)
      Difference (95%CI)                                                              0.00 (−0.02--0.02)       −0.02 (−0.03--−0.02)   Reference           0.03 (0.02--0.04)    0.05 (0.02--0.07)
  Age-adjusted mean, mm (95%CI)                                                       0.87 (0.84--0.90)        0.86 (0.83--0.88)      0.86 (0.84--0.87)   0.86 (0.83--0.88)    0.84 (0.80--0.88)
      Difference (95%CI)                                                              0.02 (0.00--0.03)        0.00 (0.00--0.00)      Reference           0.00 (−0.01--0.01)   −0.01 (−0.04--0.01)
  Multivariable-adjusted mean, mm (95%CI) (model 1)[\*](#tf7){ref-type="table-fn"}    0.87 (0.84--0.90)        0.85 (0.83--0.87)      0.85 (0.84--0.87)   0.86 (0.83--0.88)    0.85 (0.81--0.89)
      Difference (95%CI)                                                              0.02 (0.00--0.03)        0.00 (−0.01--0.00)     Reference           0.00 (0.00--0.01)    0.00 (−0.02--0.02)
  Multivariable-adjusted mean, mm (95%CI) (model 2)^[†](#tf8){ref-type="table-fn"}^   0.87 (0.84--0.90)        0.85 (0.83--0.87)      0.85 (0.84--0.87)   0.86 (0.83--0.88)    0.85 (0.81--0.89)
      Difference (95%CI)                                                              0.01 (0.00--0.03)        0.00 (−0.01--0.00)     Reference           0.00 (−0.01--0.01)   0.00 (−0.03--0.02)

Adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, and types of computed tomography scan

Adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, types of computed tomography scan, systolic blood pressure, total cholesterol, high density lipoprotein cholesterol, hemoglobin A1c, and medication status.

CI: confidence interval; IMT: intima media thickness; SESSA: Shiga Epidemiological Study of Subclinical Atherosclerosis

###### Mean IMT in selected subgroups of men enrolled SESSA (2006--2008) stratified by sleep duration (*n* = 1060)

  Subgroup                                                             Sleep duration (hours)   *p*^[†](#tf18){ref-type="table-fn"}^                                                               
  -------------------------------------------------------------------- ------------------------ -------------------------------------- ------------------- ------------------- ------------------- -------
  Age \<65 years (*n* = 531)                                           0.79 (0.75--0.82)        0.76 (0.74--0.79)                      0.78 (0.76--0.80)   0.78 (0.75--0.81)   0.81 (0.75--0.88)   0.612
  Age ≥ 65 years (*n* = 529)                                           0.96 (0.90--1.02)        0.93 (0.89--0.97)                      0.92 (0.89--0.95)   0.94 (0.90--0.97)   0.94 (0.88--0.99)   
                                                                                                                                                                                                   
  BMI \< 25 Kg/m^2^ (*n* = 752)                                        0.85 (0.81--0.89)        0.84 (0.82--0.87)                      0.84 (0.82--0.86)   0.84 (0.82--0.87)   0.84 (0.80--0.89)   0.776
  BMI ≥ 25 Kg/m^2^ (*n* = 308)                                         0.90 (0.85--0.96)        0.88 (0.85--0.91)                      0.88 (0.85--0.91)   0.89 (0.85--0.94)   0.83 (0.75--0.91)   
                                                                                                                                                                                                   
  Smoker (*n* = 336)                                                   0.86 (0.80--0.91)        0.83 (0.80--0.87)                      0.82 (0.79--0.85)   0.82 (0.78--0.86)   0.83 (0.76--0.89)   0.941
  Non-smoker (*n* = 724)                                               0.88 (0.84--0.92)        0.86 (0.84--0.89)                      0.87 (0.85--0.89)   0.87 (0.84--0.90)   0.86 (0.81--0.91)   
                                                                                                                                                                                                   
  Alcohol consumption \< 46 g/day (*n* = 862)                          0.88 (0.85--0.92)        0.86 (0.84--0.89)                      0.86 (0.84--0.88)   0.86 (0.83--0.89)   0.83 (0.79--0.87)   0.060
  Alcohol consumption ≥ 46 g/day (*n* = 198)                           0.83 (0.75--0.91)        0.80 (0.75--0.86)                      0.85 (0.80--0.90)   0.84 (0.78--0.89)   0.90 (0.81--0.99)   
                                                                                                                                                                                                   
  Working (*n* = 697)                                                  0.84 (0.81--0.88)        0.81 (0.79--0.84)                      0.83 (0.81--0.85)   0.82 (0.79--0.85)   0.85 (0.80--0.90)   0.341
  Retired (*n* = 363)                                                  0.91 (0.84--0.98)        0.93 (0.89--0.97)                      0.91 (0.87--0.94)   0.93 (0.89--0.97)   0.88 (0.82--0.94)   
                                                                                                                                                                                                   
  Did not use sleeping pills (*n* = 1001)                              0.87 (0.84--0.91)        0.85 (0.83--0.87)                      0.85 (0.83--0.87)   0.85 (0.83--0.88)   0.85 (0.81--0.89)   0.637
  Used sleeping pills (*n* = 59)                                       0.86 (0.73--0.99)        0.88 (0.80--0.97)                      0.93 (0.84--1.02)   0.91 (0.75--1.07)   0.76 (0.49--1.04)   
                                                                                                                                                                                                   
  No depressive symptoms[\*](#tf17){ref-type="table-fn"} (*n* = 977)   0.88 (0.85--0.92)        0.86 (0.83--0.88)                      0.86 (0.84--0.88)   0.86 (0.83--0.88)   0.86 (0.82--0.89)   0.601
  Depressive symptoms[\*](#tf17){ref-type="table-fn"} (*n* = 83)       0.78 (0.68--0.88)        0.80 (0.73--0.86)                      0.81 (0.73--0.90)   0.83 (0.74--0.93)   Not calculable      

Model adjusted for age, body mass index, smoking status, regular exercise, alcohol consumption, and types of computed tomography scan except for each stratified variable.

Center for Epidemiologic Studies Depression Scale score ≥ 16

Test for heterogeneity

CI: confidence interval; IMT: intima media thickness; SESSA: Shiga Epidemiological Study of Subclinical Atherosclerosi

Discussion
==========

To our knowledge, this is the first study to investigate possible associations between sleep duration and subclinical atherosclerosis in a general Japanese population. Although participants with sleep duration ≥ 8.5 h were more likely to have CAC, the association disappeared after adjustment for age. There were also no clear associations between sleep duration and carotid IMT.

Previous studies investigating these associations have shown inconsistent results^[@bib40])^ and are summarized in **[Supplementary Tables 5](#T8){ref-type="table"}** and **[6](#T9){ref-type="table"}**. The Kangbuk Samsung Health Study (*n* = 29 203, South Korea) reported a U-shaped association^[@bib23])^, whereas the Study of Women\'s Health Across the Nation (SWAN; *n* = 512, female only, United States \[USA\]) demonstrated no clear association^[@bib17])^, as did the Heart Strategies Concentrating on Risk Evaluation (HeartSCORE) study (*n* = 195, USA)^[@bib22])^. The Coronary Artery Risk Development in Young Adults (CARDIA) study (*n* = 495, USA) found increased CAC prevalence among participants with short sleep duration measured by actigraphy, but no association when sleep duration was self-reported^[@bib18])^. Heterogeneity between studies may be attributable to differences in study design, participant characteristics, method of assessment of sleep duration (self-reported or objective), or definitions of CAC used.

###### Summary of the previous studies examining the association between sleep duration and CAC

  First Author, Publication Year                    Country   Study Design             Participants           Age       Sleep Measurement                                Results
  ------------------------------------------------- --------- ------------------------ ---------------------- --------- ------------------------------------------------ ----------------------------------------------------------------------------------------------------------------------------------------------------------
  Kim *et al.*^[@bib23])^, 2015 (Samsun)            Korea     Cross-sectional          29,203 men and women   Mean 42   Self-Report (PSQI)                               U-shaped association
  Matthews *et al.*^[@bib17])^, 2013 (SWAN)         USA       Cross-sectional          512 women              Mean 50   Self-Report (PSQI)                               No clear association
  Matthews *et al.*^[@bib22])^, 2011 (HeartSCORE)   USA       Cross-sectional          195 men and women      Mean 60   Self-Report (PSQI) Actigraphy, Polysomnography   No clear association
  King *et al.*^[@bib18])^, 2008 (CARDIA)           USA       Longitudinal (5 years)   204 men 291 women      Mean 40   Self-Report (PSQI) Actigraphy                    Increased CAC prevalence among participants with short sleep dura-tion measured by actigraphy, but no clear association for self-reported sleep duration

CAC: coronary artery calcification; PSQI: Pittsburgh Sleep Quality Index

###### Summary of the previous studies examining the association between sleep duration and carotid IMT

  First Author, Publication Year             Country   Study Design      Particitants          Age 45--81   Sleep Measurement               Results
  ------------------------------------------ --------- ----------------- --------------------- ------------ ------------------------------- -----------------------------------------------------------------------------------------------------------------
  Wolff *et al.*^[@bib19])^, 2008 (SHIP)     Germany   Cross-sectional   2,437 men and women   45--81       Self-Report                     Increased carotid IMT among participants with sleep duration of \< 5 hours and \> 9 hours
  Ma *et al.*^[@bib20])^, 2013               USA       Cross-sectional   190 men 67 women      Mean 42      Self-Report (PSQI) Actigraphy   U-shaped association for sleep duration measured by actigraphy, but not for self-reported sleep duration
  Sands *et al.*^[@bib21])^, 2012 (CARDIA)   USA       Cross-sectional   260 men 357 women     37--52       Actigraphy                      Increased carotid IMT in male participants with longer objective sleep duration, but not in female participants
  Abe *et al.*^[@bib24])^, 2011              Japan     Cross-sectional   1064 men 1150 women   40--85       Self-Report                     Long sleep duration (≥ 7 h) correlated with higher incidence of carotid artery atherosclerosis

IMT: intima media thickness; PSQI: Pittsburgh Sleep Quality Index

Several observational studies in Western populations have reported higher carotid IMT among participants with short or long sleep duration, or both. The Study of Health in Pomerania (SHIPS; *n* = 2437, Germany) found a higher carotid IMT among participants with sleep duration of \< 5 h and \> 9 h^[@bib19])^. The Buffalo Cardio-Metabolic Occupational Police Stress study (*n* = 257, USA) also demonstrated a U-shaped association between carotid IMT and sleep duration measured by actigraphy, though this was not present when sleep duration was self-reported^[@bib20])^. The CARDIA study found increased carotid IMT in male participants with longer objective sleep duration, but not in female participants^[@bib21])^. Although much more limited evidence is available for Asian populations, Abe *et al.* (*n* = 2498, Japan) found increased incidence of carotid artery atherosclerosis among people with long sleep duration (≥ 7 h)^[@bib24])^. Given the equivocal results of our own study, further observation of Asian populations is needed to confirm the association between sleep duration and carotid IMT.

In contrast to the studies described above, associations between sleep duration and cardiovascular disease incidence and mortality are well described^[@bib6]--[@bib12])^. The variability may be due to differences in study design, as most studies of subclinical atherosclerosis are cross-sectional, while a most cohort studies for clinical outcomes are prospective. In fact, there has been a prospective study that demonstrated a positive association between sleep duration and progression of CAC^[@bib18])^. Further prospective investigation of sleep duration and subclinical atherosclerosis would provide a better understanding of possible associations with cardiovascular disease.

This study had several limitations. First, the cross-sectional design meant that longitudinal associations between sleep duration and atherosclerosis could not be ascertained from the data collected. Although sleep duration can be a cause as well as a consequence of atherosclerosis, a very limited number of prospective studies have investigated CAC progression. We believe the findings from this cross-sectional study, which reported the link between sleep duration and CAC in Japan for the first time, still add some epidemiological evidence to current knowledge in this area. Second, the number of subjects is somewhat small in some groups defined by sleep duration. However, this study had 80% power to detect clinically significant differences in the outcomes (≥ 36% relative increase in CAC and ≥ 0.07 mm increase in carotid IMT). In addition, estimates of sleep duration obtained through self-reported questionnaires may be limited in their accuracy, which may have biased the results to null hypothesis, and all participants were men, which may limit the generalizability of findings to women or other ethnicities.

Conclusion
==========

Self-reported sleep duration was not associated with calcification of the coronary arteries or increased carotid intima media thickness in a general population of Japanese men.

**Members of the SESSA Research Group.**

Chairperson: Hirotsugu Ueshima (Center for Epidemiologic Research in Asia, Department of Public Health, Shiga University of Medical Science, Otsu, Shiga).

Co-chairperson: Katsuyuki Miura (Department of Public Health, Shiga University of Medical Science, Otsu, Shiga).

Research members: Minoru Horie, Yasutaka Nakano, Takashi Yamamoto (Department of Cardiovascular and Respiratory Medicine, Shiga University of Medical Science, Otsu, Shiga), Emiko Ogawa (Health Administration Center, Shiga University of Medical Science, Otsu, Shiga), Hiroshi Maegawa, Itsuko Miyazawa (Division of Endocrinology and Metabolism, Department of Medicine, Shiga University of Medical Science, Otsu, Shiga), Kiyoshi Murata (Department of Radiology, Shiga University of Medical Science, Otsu, Shiga), Kenichi Mitsunami (Shiga University of Medical Science, Otsu, Shiga), Kazuhiko Nozaki (Department of Neurosurgery, Shiga University of Medical Science, Otsu, Shiga), Akihiko Shiino (Biomedical MR Science Center, Shiga University of Medical Science, Otsu, Shiga), Isao Araki (Kusatsu Public Health Center, Kusatsu, Shiga), Teruhiko Tsuru (Department of Urology, Shiga University of Medical Science, Otsu, Shiga), Ikuo Toyama (Unit for Neuropathology and Diagnostics, Molecular Neuroscience Research Center, Shiga University of Medical Science, Otsu, Shiga), Hisakazu Ogita, Souichi Kurita (Division of Medical Biochemistry, Department of Biochemistry and Molecular Biology, Shiga University of Medical Science, Otsu, Shiga), Toshinaga Maeda (Central Research Laboratory, Shiga University of Medical Science, Otsu, Shiga), Naomi Miyamatsu (Department of Clinical Nursing, Shiga University of Medical Science, Otsu, Shiga), Toru Kita (Kobe City Medical Center General Hospital, Kobe, Hyogo), Takeshi Kimura (Department of Cardiovascular Medicine, Kyoto University, Kyoto), Yoshihiko Nishio (Department of Diabetes, Metabolism, and Endocrinology, Kagoshima University, Kagoshima), Yasuyuki Nakamura (Department of Food Science and Human Nutrition, Faculty of Agriculture, Ryukoku University, Otsu, Shiga), Tomonori Okamura (Department of Preventive Medicine and Public Health, School of Medicine, Keio University, Tokyo), Akira Sekikawa, Emma JM Barinas-Mitchell (Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA), Daniel Edmundowicz (Department of Medicine, Section of Cardiology, School of Medicine, Temple University, Philadelphia, PA, USA), Takayoshi Ohkubo (Department of Hygiene and Public Health, Teikyo University School of Medicine, Tokyo), Atsushi Hozawa (Preventive Medicine, Epidemiology Section, Tohoku University, Tohoku Medical Megabank Organization, Sendai, Miyagi), Nagako Okuda (Department of Health and Nutrition, University of Human Arts and Sciences, Saitama), Aya Higashiyama (Research and Development Initiative Center, National Cerebral and Cardiovascular Center, Suita, Osaka), Shinya Nagasawa (Department of Epidemiology and Public Health, Kanazawa Medical University, Kanazawa, Ishikawa), Yoshikuni Kita (Faculty of Nursing Science, Tsuruga Nursing University, Tsuruga, Fukui), Yoshitaka Murakami (Division of Medical Statistics, Department of Social Medicine, Toho University, Tokyo), Aya Kadota (Center for Epidemiologic Research in Asia, Department of Public Health, Shiga University of Medical Science, Otsu, Shiga), Akira Fujiyoshi, Naoyuki Takashima, Takashi Kadowaki, Sayaka Kadowaki (Department of Public Health, Shiga University of Medical Science, Otsu, Shiga), Robert D. Abbott, Seiko Ohno (Center for Epidemiologic Research in Asia, Shiga University of Medical Science, Otsu, Shiga), Hisatomi Arima (Department of Preventive Medicine and Public Health, Faculty of Medicine, Fukuoka University, Fukuoka), Takashi Hisamatsu (Department of Environmental Medicine and Public Health, Faculty of Medicine, Shimane University, Izumo, Shimane), Naoko Miyagawa, Keiko Kondo, Sayuki Torii, Yoshino Saito, Maryam Zaid, Sentaro Suzuki, Takahiro Ito, Masahiro Yamazoe, Takeshi Shibukawa, and Masaki Sumi (Department of Public Health, Shiga University of Medical Science, Otsu, Shiga).

Notice of Grant Support
=======================

This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan (Grants-in-Aid for Scientific Research: (A) 13307016; (A) 17209023; (A) 21249043; (A) 23249036; (A) 25253046; (A) 15H02528; and (B) 15H04773), and by GlaxoSmithKlein (grant R01HL068200).

COI
===

The authors declare no potential conflicts of interest with regard to this manuscript.
